METTL3 not only promotes HCC advancement through YTHDF2-dependent posttranscriptional silencing of SOCS2 (21), but also facilitates CRC progression via IGF2BP2-dependent stabilizing of SOX2 mRNA (19). The gene discussed is SOX2; the disease is colorectal carcinoma.